Institutional investors purchased a net $629.9 thousand shares of ABIO during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 4.18% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 151.3 Thousand shares of ARCA Biopharma Inc